Background There is considerable practice variation in labelling, diagnosis and treatment of adults with sterile bone inflammation. We developed a expert consensus recommendations on the disease ...
15 Department of Radiology. Leiden University Medical Centre, Leiden, The Netherlands 16 Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands ...
Objective We aimed to investigate the relationship between tumour necrosis factor inhibitors (TNFi) therapy and the onset of new psoriasis in children with juvenile idiopathic arthritis (JIA) using ...
Correspondence to Dr Lili Zhao, Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA; zhaolili{at}med.umich.edu Objectives We intended to assess the effectiveness of all three ...
1 Department of Anatomy, Histology and Forensic Medicine, University of Florence, Florence, Italy 2 Department of Biomedicine, Division of Rheumatology, AOUC, and Excellence Centre for Research, ...
Correspondence to Professor Iain B McInnes, Division of Immunology, Infection and Inflammation, Faculty of Medicine, University of Glasgow, 120 University Avenue, Glasgow G12 8TA, UK; ...
Background Total knee replacement (TKR) revolutionized management of patients with advanced knee osteoarthritis and rheumatoid arthritis, in order to help them overcome pain and functional limitation, ...
1 Department of Molecular Cell Biology, VU Medical Centre/VU University Amsterdam, 1081 BT Amsterdam, The Netherlands 2 Division of Clinical Immunology and Rheumatology, Academic Medical ...
Objectives We aim to investigate the genetic basis of a case of late-onset autoinflammatory disease characterised by arthritis, recurrent fever and skin rashes. Methods We performed whole-exome/genome ...
Dr C H M van den Ende, Leiden University Medical Centre, Department of Rheumatology, C4-R, Postbox 9600, 2300 RC Leiden, The Netherlands Email:e.vandenende{at}nivel.nl OBJECTIVE To investigate the ...
For more than three decades, low-dose methotrexate (MTX) has been the first-line treatment for patients with rheumatoid arthritis (RA). Even after the introduction of biologics/biosimilars and janus ...